Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Morphochem enters research collaboration with AstraZeneca for novel antithrombotics

Nov. 27, 2002

Series of esterase-susceptible anticoagulants covered by ARYx patent

Nov. 25, 2002

New PAR1 antagonists discovered by Eisai scientists

Nov. 25, 2002

Prehospital TNKase treatment of heart attack feasible and faster than in-hospital treatment

Nov. 25, 2002

New antithrombotic compounds under study at Boehringer Ingelheim

Nov. 21, 2002

First safety and pharmacokinetic data of the thrombolytic BB-10153 in humans

Nov. 20, 2002

Effects of DPC-423 in rabbit model suggest clinical utility in preventing arterial thrombosis

Nov. 19, 2002

Novel target to prevent heart attacks and strokes discovered at Lexicon

Nov. 19, 2002

New alphavbeta6 integrin antagonists in early development at Merck KGaA

Nov. 18, 2002

Oral factor Xa inhibitor enters phase I study for the treatment of thrombotic diseases

Nov. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...